Longevity Research
Longevity-focused peptide research has grown nearly 300% year-over-year in search volume, reflecting the broader expansion of interest in cellular aging mechanisms. NAD+ and GHK-Cu represent two distinct but complementary areas of this research: NAD+ at the metabolic and epigenetic level, and GHK-Cu at the tissue regeneration and gene expression level.
Both are studied as research compounds in laboratory settings. Neither should be interpreted as having approved therapeutic applications for human anti-aging use.
NAD+ is a coenzyme found in every living cell, central to redox reactions and energy metabolism. Cellular NAD+ levels decline with age in multiple tissue types, a finding that has generated significant research interest in NAD+ replenishment and its downstream effects.
Key research areas include:
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex found in human plasma. It was first isolated in the 1970s and has since accumulated a substantial research literature focused on its effects on tissue remodeling and gene expression.
GHK-Cu research contexts include:
NAD+ and GHK-Cu address aging biology at different levels — one metabolic and epigenetic, one extracellular and structural. Research programs exploring multi-pathway longevity mechanisms frequently incorporate both. This is reflected in our GLOW blend, which pairs GHK-Cu with BPC-157 and TB-500 for researchers studying overlapping tissue repair and remodeling pathways.
Plato Peptides supplies both NAD+ (500mg) and GHK-Cu (as part of the GLOW blend) at verified purity with independent COA documentation.